VaxGen receives first BioShield contract for anthrax vaccine
84259
Shares of VaxGen Inc. surged 17 percent Friday after the government said it would buy 75 million doses of a new generation anthrax vaccine under an $877.
307115
GlaxoSmithKline Plc&#39;s experimental vaccine was effective against a virus that causes cervical cancer in a study, the first to show the treatment may provide protection against the No.
688592
The U.S. government on Tuesday awarded Sanofi-Aventis  a contract worth up to &#36;41 million through 2008 to ensure enough eggs are available for future flu vaccine production.
582357
NEW YORK  - Immunization through the skin,  using a patch, protects mice against normally lethal inhaled  doses of anthrax bacteria, according to a new report.
196423
VaxGen Inc. will make a new and improved version of the anthrax vaccine for use in case of a biological attack, the US government said on Thursday.
681170
Chiron Corp. (CHIR.O) has won a contract to develop a human vaccine against a strain of bird flu that can infect people and "has the potential to trigger a modern-day pandemic," the U.S. government said on Tuesday.
525510
Synthetically produced antibodies that target a component of the anthrax toxin may reduce illness and death due anthrax exposure, even after shock has set in, rat studies indicate.
567349
Under the Project Bioshield program, firm will make 75 million doses of a newly developed vaccine.
623395
Biogen Idec Inc. of Cambridge said it is in final discussions with the Food and Drug Administration about its new multiple sclerosis drug Antegren, and expects the drug to be approved by the end of the month.
364081
Sep 21, 2004 (CIDRAP News) - In a bid to limit the threat of an influenza pandemic, the Department of Health and Human Services (HHS) is awarding a contract to Aventis Pasteur Inc.
566278
Merck & Co Inc's Gardasil, the first  vaccine to prevent cervical cancer, has been approved for sale  in the Europe Union, the joint venture that will market the  product in Europe said on Friday.
185303
Chiron Corp. has won a contract to  develop a human vaccine against a strain of bird flu that can  infect people and "has the potential to trigger a modern-day  pandemic," the U.S. government said on Tuesday.
88897
The US Department of Health and Human Services has awarded a contract to Aventis Pasteur Inc. to make and store two million doses of avian influenza H5N1 vaccine, it was announced Tuesday.
294882
THE United States has ordered 75 million doses of a new anthrax vaccine, costing $1.16 billion, from pharmaceutical VaxGen, health secretary Tommy Thompson said today.
22037
California vaccine maker VaxGen Inc. will make a new and improved version of the anthrax vaccine for use in case of a biological attack, the U.S. government said on Thursday.
690338
WASHINGTON Nov 4, 2004 - The government said Thursday it is purchasing 75 million doses of a new generation anthrax vaccine under an $877.
638522
The government plans to develop an experimental treatment for anthrax from the blood of people vaccinated against it. Such a medicine has never been tested on people, but scientists think it has a good chance of working based on animal tests. Federal ...